Douglas L. Braunstein, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 218,446 shares at $57.95 ($12.5M) on 2019-05-09, disclosed to the SEC on 2019-05-13.
Open-market sale of $12.5M EGRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.95 | 59,223 | $3.4M | 27.5% |
| 2 | $57.95 | 59,223 | $3.4M | 27.5% |
| 3 | $56.14 | 100,000 | $5.6M | 45.0% |
| Total | $57.12 avg | 218,446 | $12.5M | 100% |
| Filing → |
| TALK | BUY | 2021-06-24 | $50.0M | — | Filing → |
| HCII | SELL | 2021-04-14 | $0 | — | Filing → |
| EGRX | SELL | 2019-10-15 | $716K | — | Filing → |